Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six casesAli Theibich, Henning Locht, Lene Dreyer et al.|Clinical Rheumatology|2013Cited by 53
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and SwedenTine Iskov Kopp, Lene Dreyer, Elizabeth V. Arkema et al.|Annals of the Rheumatic Diseases|2020Cited by 48
Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis RegistryLene Dreyer, Henning Locht, Melinda Magyari et al.|Annals of the Rheumatic Diseases|2015Cited by 44